Skip to main content

Want a detailed portfolio tracker?

Edesa Biotech (EDSA) P/E (2015 - 2026)

Edesa Biotech (EDSA) P/E from Nov 5, 2015 to Jul 21, 2026. The TTM Edesa Biotech (EDSA) P/E is -4.62. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Edesa Biotech (EDSA)

YearP/EChange
2026-4.62+243.87%
2025-1.34+48.25%
2024-0.91-42.97%
2023-1.59-14.57%
2022-1.86-77.62%
2021-8.30-73.04%
2020-30.81-61.99%
2019-81.04-483.55%
201821.13-83.95%
2017131.66-60.10%
2016329.95-68.72%
20151.05KN/A

Comparison Edesa Biotech (EDSA) P/E with competitors

Edesa Biotech (EDSA) P/E is -4.62.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.62%
FGENFibroGen Inc0.24-105.20%
CHRSCoherus Biosciences Inc0.85-118.38%
FBIOFortress Biotech Inc0.95-120.56%
ORMPOramed Pharmaceuticals Inc1.50-132.56%
AGENAgenus Inc3.01-165.20%
INVAInnoviva Inc3.15-168.33%
VXRTVaxart Inc3.55-176.90%
CRMDCorMedix Inc3.63-178.60%
CVACCureVac N.V.4.45-196.31%
GLPGGalapagos NV4.86-205.26%
SRPTSarepta Therapeutics Inc4.88-205.76%
ABEOAbeona Therapeutics Inc5.39-216.71%
ABUSArbutus Biopharma Corp5.60-221.22%
ZVRAZevra Therapeutics Inc5.89-227.54%
SPROSpero Therapeutics Inc6.23-234.93%
CGENCompugen Ltd6.31-236.78%
RIGLRigel Pharmaceuticals6.87-248.87%
SLXNSilexion Therapeutics Corp7.30-258.06%
OMEROmeros Corporation9.26-300.57%
AUPHAurinia Pharmaceuticals Inc9.58-307.64%
PLXProtalix BioTherapeutics Inc10.89-335.93%
ACADAcadia Pharmaceuticals Inc11.73-354.08%
TBPHTheravance Biopharma Inc12.26-365.64%
ADMAAdma Biologics Inc12.42-369.02%
HRMYHarmony Biosciences Holdings Inc13.82-399.39%
SABSSAB Biotherapeutics Inc14.14-406.24%
NAGENiagen Bioscience Inc14.82-421.01%
INCYIncyte Corp15.82-442.77%
REGNRegeneron Pharmaceuticals Inc15.86-443.51%
PBYIPuma Biotechnology Inc17.32-475.12%
CPRXCatalyst Pharmaceuticals Inc17.44-477.79%
EXELExelixis Inc17.54-479.93%
TGTXTG Therapeutics Inc18.97-510.87%
MDXGMimedx Group Inc20.55-545.24%
XOMAXOMA Royalty Corp22.87-595.55%
ARGXArgen X SE24.30-626.39%
CTMXCytomX Therapeutics Inc24.82-637.72%
XOMAOXOMA Royalty Corp25.34-649.07%
HALOHalozyme Therapeutics Inc25.62-655.11%
XOMAPXOMA Royalty Corp25.67-656.11%
VRTXVertex Pharmaceuticals Inc27.99-706.47%
RPRXRoyalty Pharma plc - Class A28.69-721.48%
SLNOSoleno Therapeutics Inc29.02-728.59%
ASNDAscendis Pharma A/S30.09-751.77%
LGNDLigand Pharmaceuticals Inc - Class B37.91-921.32%
APLSApellis Pharmaceuticals Inc39.02-945.35%
BMRNBiomarin Pharmaceutical Inc42.21-1014.47%
KRYSKrystal Biotech Inc45.34-1082.32%
ONCBeiGene Ltd69.54-1606.52%
PHARPharming Group N.V.75.03-1725.35%
TECHBio-Techne Corp101.96-2308.82%
VCELVericel Corp109.92-2481.32%
ALNYAlnylam Pharmaceuticals Inc117.96-2655.58%
GMABGenmab140.29-3139.25%
TLXTelix Pharmaceuticals Ltd162.15-3612.86%
CORTCorcept Therapeutics Inc212.86-4711.32%